Oric Pharmaceuticals Inc
(ORIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||
| Net Income | -11,980 | -6,015 | -21,363 |
| Depreciation Amortization | 488 | 242 | 903 |
| Other Working Capital | 83 | 51 | -707 |
| Other Operating Activity | 384 | 191 | 484 |
| Operating Cash Flow | $-11,025 | $-5,531 | $-20,683 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -493 | -100 | 0 |
| Net Acquisitions | N/A | N/A | -525 |
| Other Investing Activity | 0 | 0 | 17 |
| Investing Cash Flow | $-493 | $-100 | $-508 |
| Cash Flows From Financing Activities | |||
| Common Stock Issued | 80 | 21 | N/A |
| Other Financing Activity | 65,107 | 15,243 | 38,008 |
| Financing Cash Flow | $65,187 | $15,264 | $38,008 |
| Beginning Cash Position | 42,636 | 42,636 | 25,819 |
| End Cash Position | 96,305 | 52,269 | 42,636 |
| Net Cash Flow | $53,669 | $9,633 | $16,817 |
| Free Cash Flow | |||
| Operating Cash Flow | -11,025 | -5,531 | -20,683 |
| Capital Expenditure | -493 | -100 | N/A |
| Free Cash Flow | -11,518 | -5,631 | -20,683 |